Large-Joint Reconstructive Implants | Medtech 360 | Market Analysis | US | 2019
|発行||Millennium Research Group - DRG||商品コード||233584|
|米国の大関節再建インプラント市場 Large-Joint Reconstructive Implants | Medtech 360 | Market Analysis | US | 2019|
|出版日: 2018年12月14日||ページ情報: 英文||
当レポートでは、米国の大関節再建インプラント市場について調査分析し、現在・将来の動向 (件数、売上、平均販売価格、市場価値) 、競合情勢、主要企業の市場シェアについて、体系的な情報を提供しています。
Demand for better patient outcomes will drive the uptake of novel technologies such as patient-conforming and 3-D printed implants, robotic- and navigation-assisted surgeries, and minimally invasive techniques, supporting the expansion of the US large-joint reconstructive implant market through 2027; however, downward pricing pressures driven by bundled payment initiatives such as the CJR and BPCI Advanced models, growing outpatient joint replacement volumes, and the increasing influence of GPOs will limit overall revenue potential to some degree.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 10-year period.
How do the CJR and BPCI Advanced models differ from each other?
How will the risk profile of patients in different sites of service change with the introduction of these models?
How will physician treatment practices change in response to bundled payment models?
How will product mix, procedure volumes, and ASPs be affected by bundled payment models?
What strategies are companies employing to succeed with the expansion of these models?
Which procedures are seeing an increasing shift to outpatient settings?
How will differing reimbursement rates in hospital versus nonhospital settings affect product choices and treatment approaches?
How can companies tailor their strategies to cater to the needs of hospital outpatient departments and ASCs?
What technologies are being developed to enable shorter surgery and recovery times in outpatient settings?
What are the current purchasing priorities of health care facilities?
How are health care facilities adding value to preoperative and postoperative care?
What strategies and added services are orthopedic manufacturers adopting in response to shifting hospital demands?
How are companies reacting to the trends surrounding robotic assistance, navigation technologies, and personalized implants?
How important is clinical data to the adoption of newer materials and technologies in this space, given the large number of recalls and lawsuits against device manufacturers?
How are innovative technologies and value-based solutions affecting market share shifts?
Author(s): Mohith Unny, MSc
Mohith Unny is a senior analyst within the Orthopedics Medtech Insights team at Decision Resources Group. Mohith holds a Master's degree in Advanced Chemical Engineering from Imperial College London and was awarded the Prof. Geoffrey F. Hewitt Prize 2014/15.